Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sebag

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2010
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawalD Taïeb, F Sebag, B Farman-Ara, et al.
Endocrine Connections|September 14, 2017
Investigating the association of rs2910164 with cancer predisposition in an Irish cohortT P McVeigh, R J Mulligan, U M McVeigh, et al.
Clinical Endocrinology|September 23, 2008
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled studyD Taïeb, F Sebag, M Cherenko, et al.
Langenbeck'S Archives of Surgery|December 20, 2012
Pheochromocytoma revealed by acute heart failure. When should we operate? Presented at the ESES Congress, Gothenburg May 25-26, 2012G Müller, F Saint, A Hamy, et al.
Clinical Endocrinology|November 3, 2010
Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalitiesN Charrier, A Deveze, N Fakhry, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2010
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawalD Taïeb, F Sebag, B Farman-Ara, et al.
Endocrine Connections|September 14, 2017
Investigating the association of rs2910164 with cancer predisposition in an Irish cohortT P McVeigh, R J Mulligan, U M McVeigh, et al.
Clinical Endocrinology|September 23, 2008
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled studyD Taïeb, F Sebag, M Cherenko, et al.
Langenbeck'S Archives of Surgery|December 20, 2012
Pheochromocytoma revealed by acute heart failure. When should we operate? Presented at the ESES Congress, Gothenburg May 25-26, 2012G Müller, F Saint, A Hamy, et al.
Clinical Endocrinology|November 3, 2010
Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalitiesN Charrier, A Deveze, N Fakhry, et al.
Pageof 8